Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03265925 · ClinicalTrials.gov registry record
Brain Network Activation Analysis in Epilepsy
A clinical trial, sponsored by ElMindA.
- Completed
- Registry status
- 1
- Enrollment target
NCT03265925: Completed study, sponsored by ElMindA.
NCT03265925 is a clinical trial that has completed, run by ElMindA. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03265925 has completed, sponsored by ElMindA.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
This is a prospective study investigating the utility of Brain Network Activation (BNA) analysis in patients with epilepsy.
Primary Outcome
Functional networks of brain activity in Epilepsy (Right and Left lobe) and healthy control individuals measured using analysis of EEG Event Related Potential (ERP) data. Clinical assessments battery will be utilized in order to examine different sets of BNA database for Epilepsy pathology and healthy controls.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-05-26 |
| Est. Completion | 2018-05-08 |
What the finished NCT03265925 record still lists
NCT03265925 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03265925 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03265925 about?
NCT03265925 is a clinical study titled "Brain Network Activation Analysis in Epilepsy". This is a prospective study investigating the utility of Brain Network Activation (BNA) analysis in patients with epilepsy.
What is the current status of trial NCT03265925?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2017-05-26. Estimated completion is 2018-05-08.
Who is sponsoring clinical trial NCT03265925?
This trial is sponsored by ElMindA, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI